204 related articles for article (PubMed ID: 34046344)
1. Targeted Therapy With PI3K and FGFR Inhibitors on Human Papillomavirus Positive and Negative Tonsillar and Base of Tongue Cancer Lines With and Without Corresponding Mutations.
Holzhauser S; Wild N; Zupancic M; Ursu RG; Bersani C; Näsman A; Kostopoulou ON; Dalianis T
Front Oncol; 2021; 11():640490. PubMed ID: 34046344
[TBL] [Abstract][Full Text] [Related]
2.
Holzhauser S; Kostopoulou ON; Ohmayer A; Lange BKA; Ramqvist T; Andonova T; Bersani C; Wickström M; Dalianis T
Oncol Lett; 2019 Dec; 18(6):6249-6260. PubMed ID: 31788102
[TBL] [Abstract][Full Text] [Related]
3. Targeted Therapy of HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy between CDK4/6, PI3K and Sometimes FGFR Inhibitors, but Rarely between PARP and WEE1 Inhibitors.
Kostopoulou ON; Zupancic M; Pont M; Papin E; Lukoseviciute M; Mikelarena BA; Holzhauser S; Dalianis T
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891353
[TBL] [Abstract][Full Text] [Related]
4. Curcumin Alone and Combined With PI3K Inhibitors Elicits Positive Effects on Oropharyngeal Cancer Cell Lines Regardless of HPV Status.
Lukoceviciute M; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T
Anticancer Res; 2024 May; 44(5):1863-1876. PubMed ID: 38677772
[TBL] [Abstract][Full Text] [Related]
5. Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited.
Byskata K; Lukoseviciute M; Tuti F; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612094
[TBL] [Abstract][Full Text] [Related]
6. Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3.
Bersani C; Sivars L; Haeggblom L; DiLorenzo S; Mints M; Ährlund-Richter A; Tertipis N; Munck-Wikland E; Näsman A; Ramqvist T; Dalianis T
Oncotarget; 2017 May; 8(21):35339-35350. PubMed ID: 28525363
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of FGFR3 in HPV-positive Tonsillar and Base of Tongue Cancer Is Correlated to Outcome.
Bersani C; Haeggblom L; Ursu RG; Giusca SE; Marklund L; Ramqvist T; Näsman A; Dalianis T
Anticancer Res; 2018 Aug; 38(8):4683-4690. PubMed ID: 30061236
[TBL] [Abstract][Full Text] [Related]
8. Protein Expression in Tonsillar and Base of Tongue Cancer and in Relation to Human Papillomavirus (HPV) and Clinical Outcome.
Ramqvist T; Näsman A; Franzén B; Bersani C; Alexeyenko A; Becker S; Haeggblom L; Kolev A; Dalianis T; Munck-Wikland E
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587383
[TBL] [Abstract][Full Text] [Related]
9. Analyses of FGFR3 and PIK3CA mutations in neuroblastomas and the effects of the corresponding inhibitors on neuroblastoma cell lines.
Kostopoulou ON; Holzhauser S; Lange BKA; Ohmayer A; Andonova T; Bersani C; Wickström M; Dalianis T
Int J Oncol; 2019 Dec; 55(6):1372-1384. PubMed ID: 31638167
[TBL] [Abstract][Full Text] [Related]
10. Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8 - Risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue carcinomas.
Marklund L; Holzhauser S; de Flon C; Zupancic M; Landin D; Kolev A; Haeggblom L; Munck-Wikland E; Hammarstedt-Nordenvall L; Dalianis T; Näsman A
Eur J Cancer; 2020 Nov; 139():192-200. PubMed ID: 32951963
[TBL] [Abstract][Full Text] [Related]
11. Incidence of human papillomavirus positive tonsillar and base of tongue carcinoma: a stabilisation of an epidemic of viral induced carcinoma?
Näsman A; Nordfors C; Holzhauser S; Vlastos A; Tertipis N; Hammar U; Hammarstedt-Nordenvall L; Marklund L; Munck-Wikland E; Ramqvist T; Bottai M; Dalianis T
Eur J Cancer; 2015 Jan; 51(1):55-61. PubMed ID: 25466506
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus and tonsillar and base of tongue cancer.
Ramqvist T; Grün N; Dalianis T
Viruses; 2015 Mar; 7(3):1332-43. PubMed ID: 25803099
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus and survival of patients per histological subsite of tonsillar squamous cell carcinoma.
Haeggblom L; Attoff T; Hammarstedt-Nordenvall L; Näsman A
Cancer Med; 2018 May; 7(5):1717-1722. PubMed ID: 29573210
[TBL] [Abstract][Full Text] [Related]
14. The value of p16 and HPV DNA in non-tonsillar, non-base of tongue oropharyngeal cancer.
Hammarstedt L; Holzhauser S; Zupancic M; Kapoulitsa F; Ursu RG; Ramqvist T; Haeggblom L; Näsman A; Dalianis T; Marklund L
Acta Otolaryngol; 2021 Jan; 141(1):89-94. PubMed ID: 32940116
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Markers and Driver Genes and Options for Targeted Therapy in Human-Papillomavirus-Positive Tonsillar and Base-of-Tongue Squamous Cell Carcinoma.
Näsman A; Holzhauser S; Kostopoulou ON; Zupancic M; Ährlund-Richter A; Du J; Dalianis T
Viruses; 2021 May; 13(5):. PubMed ID: 34069114
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Survival and Recurrence in Oropharyngeal Squamous Cell Carcinoma in Relation to Subsites, HPV, and p16-Status.
Wendt M; Hammarstedt-Nordenvall L; Zupancic M; Friesland S; Landin D; Munck-Wikland E; Dalianis T; Näsman A; Marklund L
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34070952
[TBL] [Abstract][Full Text] [Related]
17. Effects of PI3K and FGFR inhibitors alone and in combination, and with/without cytostatics in childhood neuroblastoma cell lines.
Holzhauser S; Lukoseviciute M; Papachristofi C; Vasilopoulou C; Herold N; Wickström M; Kostopoulou ON; Dalianis T
Int J Oncol; 2021 Feb; 58(2):211-225. PubMed ID: 33491755
[TBL] [Abstract][Full Text] [Related]
18. Changes in incidence and prevalence of human papillomavirus in tonsillar and base of tongue cancer during 2000-2016 in the Stockholm region and Sweden.
Haeggblom L; Attoff T; Yu J; Holzhauser S; Vlastos A; Mirzae L; Ährlund-Richter A; Munck-Wikland E; Marklund L; Hammarstedt-Nordenvall L; Ye W; Ramqvist T; Näsman A; Dalianis T
Head Neck; 2019 Jun; 41(6):1583-1590. PubMed ID: 30584688
[TBL] [Abstract][Full Text] [Related]
19. Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years.
Haeggblom L; Ramqvist T; Tommasino M; Dalianis T; Näsman A
Papillomavirus Res; 2017 Dec; 4():1-11. PubMed ID: 29179862
[TBL] [Abstract][Full Text] [Related]
20. A global epidemic increase of an HPV-induced tonsil and tongue base cancer - potential benefit from a pan-gender use of HPV vaccine.
Näsman A; Du J; Dalianis T
J Intern Med; 2020 Feb; 287(2):134-152. PubMed ID: 31733108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
